Symposium “Plants in Health and Culture”
Abstract of "Central Asian Ritual and Psychoactive Plants"
David S. Flattery, University of California, Berkeley
Abstract
In this paper I propose that the identification of *sauma as ephedra implies
that the *sauma ceremonies were based on the use of Peganum harmala (harmel),
the most abundant intoxicant plant of central Asia.
I argue that the *sauma ceremony was a formalized procedure intended to show the
integrity of priests based on their willingness to risk drinking a drug the
effects of which could result in exposing deceitful intentions. In the ceremony
a priest drank *sauma, to which, without his knowledge, such a drug might have
been added. *Sauma designated a role in this ceremony and was not originally a
plant name. *Sauma came to designate ephedra because ephedra was the plant most
suited to this role, which was not that of a drug but of a constant to which a
drug might be added.
The etymological meaning of *sauma refers to the process of extraction by mortar
and pestle. That process may have characterized the preparation of the drug
plant sometimes extracted with *sauma/ephedra. It is improbable that the process
of mortar and pestle extraction could have referred originally to the extraction
of ephedrine from ephedra because mortaring is an inefficient way of obtaining
ephedrine. Extracts of ephedra so prepared contain sub threshold quantities of
ephedra. However, in the presence of harmel alkaloids the action of ephedrine
may be intensified as much as four fold and could significantly alter the
effects of harmel.
The argument that the drug sometimes extracted with *sauma was harmel is based
(1) on this intensifying action of harmel alkaloids upon ephedrine; (2) on the
suitability of harmel effects for inducing behavior that could expose deceitful
intentions; and (3) on the necessity of using mortar and pestle to prepare
harmel as a drug. There is, however, little ethnographic evidence of the
combination of harmel and ephedra in Iranian folkways and the published
pharmacological evidence for their interaction is indirect. A clinical
experiment might be designed that could falsify this aspect of the argument.
References to *sauma intoxication in the hymns accompanying the *sauma ceremony
were to invoke benign effects should the *sauma contain the intoxicant. They
refer to the intoxication of the added plant but are not descriptive of how its
intoxication was actually experienced.
Some implications of my arguments are to refute (1) the claims of V. I.
Sarianidi to have identified haoma temples in Central Asia; (2) the idea that *sauma
was not originally Indo-Iranian but was borrowed from a substrate culture; (3)
the theory that the soma plant of the Rigveda was an intoxicant plant, such as
Amanita muscaria, that disappeared and was replaced by substitutes or by
different ceremonies; and (4) the proposition that ephedra, although it was
certainly *sauma and was *sauma by reason of the stimulant properties of the
ephedrine it may contain, was consumed as *sauma in order to experience
stimulation.